| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,008 | 6,605 | 3,990 | 2,942 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 4,008 | 6,605 | 3,990 | 2,942 | | | Operating Expenses | | Research Development | 12,912 | 17,650 | 15,818 | 15,377 | | Selling General and Administrative | 5,633 | 5,836 | 6,274 | 6,200 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,537) | (16,881) | (18,102) | (18,635) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27 | 258 | 359 | 442 | | Earnings Before Interest And Taxes | (14,510) | (16,623) | (17,743) | (18,193) | | Interest Expense | 136 | 149 | 162 | 176 | | Income Before Tax | (14,646) | (16,772) | (17,905) | (18,369) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,646) | (16,772) | (17,905) | (18,369) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,646) | (16,772) | (17,905) | (18,369) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,646) | ($16,772) | ($17,905) | ($18,369) |
|
0.49% Nasdaq 0.00%
Income Statement
